Immunoconjugate
From Infogalactic: the planetary knowledge core
Immunoconjugates are antibodies conjugated (joined) to a second molecule, usually a toxin, radioisotope or label.[1]
These conjugates are used in immunotherapy[citation needed] and to develop monoclonal antibody therapy as a targeted form of chemotherapy[2] when they are often known as antibody-drug conjugates.
When the conjugates include a radioisotope see radioimmunotherapy. When the conjugates include a toxin see immunotoxin.
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." />Further reading
- Technology Insight: cytotoxic drug immunoconjugates for cancer therapy. 2007 looks useful from the abstract.
- Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates. 2006 full article, 18 pages.
- Arming antibodies: prospects and challenges for immunoconjugates. 2005 10 pages.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This immunology article is a stub. You can help Wikipedia by expanding it. |
